fbpx

News

Introducing Seamaty’s Latest Innovations: SD3 & Lab 3Dx

As a global leader in point-of-care (POC) diagnostics since 2012, Chengdu Seamaty Technology Co., Ltd. continues to push boundaries in medical and veterinary testing. Today, we proudly unveil two groundbreaking solutions designed to empower healthcare providers and veterinarians with precision, efficiency, and versatility: the SD3 Fully Automated Dry Chemistry Analyzer and the Lab 3Dx Multifunctional Veterinary Diagnosis [...]

By |2025年7月22日|Posts|0 Comments

Chengdu Seamaty Technology Co., Ltd.: Pioneering POCT Medical Solutions

Company Development History Since its establishment in 2012, Chengdu Seamaty Technology Co., Ltd. has been dedicated to the research, development, production, and sales of Point-of Care Testing (POCT) medical devices and reagents. Over the past decade, the company has accumulated extensive industry experience and established itself as a significant player in the medical diagnostics field. Starting as a local enterprise, Seamaty has grown into an international company with a global presence, continuously pushing the boundaries of medical technology innovation. Company Main Products Seamaty currently offers five major categories of diagnostic products: [...]

By |2025年7月16日|Posts|0 Comments

Portable Blood Gas Analyzer | Seamaty SG1 for Lab-Quality Results in Minutes

Looking for a portable blood gas analyzer that delivers lab-quality diagnostic results? Meet the Seamaty SG1, a handheld blood gas analyzer designed for rapid, accurate testing in any setting. Whether you need a point [...]

By |2025年7月11日|Posts|0 Comments

Introducing the SD3 Fully Automated Chemistry Analyzer: Elevate Your Diagnostic Capabilities

In the ever-evolving world of medical diagnostics, efficiency, accuracy, and versatility are paramount. At Chengdu Seamaty Technology Co., Ltd, we are proud to introduce our latest innovation, the SD3 Fully Automated Chemistry Analyzer, a game-changer in the field of clinical diagnostics. A [...]

By |2025年7月11日|Posts|0 Comments
Go to Top